In July, the Taiwan Food and Drug Administration (FDA) approved Medigen’s emergency use (EUA) based on a controversial criterion for assessing neutralizing antibody levels in vaccinated people. The panel of experts that made the approval decision argued that in patients who participated in the second phase of testing, the seroconversion was 95.5%.
In recent months, the Taiwanese government decided to sign contracts with two local companies, Medigen and United Biomedical, to purchase a total of 10 million vaccines. United Biomedical, although the second phase of research has been completed, unlike Medigen, has not yet received an EUA.
The decision to grant Medigen EUA raises some controversy in Taiwan, where the setting has been approved ahead of the third phase of research, which is currently underway in Paraguay. Opposition voices were repeated by the opposition Kuomintang, arguing that the vaccine was approved too quickly.
Some Taiwanese experts point out that distrust of the vaccine is only due to the fact that the research results have not been published in reputable journals, as was the case with AstraZeneca or Johnson & Johnson vaccines.
Medigen vaccine is approved for people over 20 years of age; The preparation will be given in two doses every 28 days apart.
The next round of registration for immunizations begins on Monday – everyone from the age of 36 will have the opportunity to register for immunizations. This is the second round of enrollment in which Medigen is included. Previously, about 1 million people expressed their desire to adopt a local setting.
Chief Caj Ing-wen was among those who registered for vaccination with Medigen. Cage’s involvement in vaccination aims to convince reluctant citizens that Taiwanese vaccines are safe and effective.
Vaccine shortages in recent months have been one of the most pressing problems facing a country of 24 million people. Despite the purchase of 20 million doses of foreign preparations, only half of them have reached Taiwan so far. Almost all preparations were used. The first dose of AstraZeneka or Moderna has been received by more than 9 million citizens and residents. Only two doses have been received by 650,000. Persons.
Only three new cases of the local coronavirus were recorded in Taiwan on Saturday, the lowest number since record growth in mid-May. That’s a significant drop, considering that the daily record in May was more than 500 local cases. Over the past week, that number has remained around 10 infections per day – most of those infected locally are people in quarantine. Only one of the three injuries on Saturday is unknown – its source has been clarified.
Thus, the situation in the country was almost completely controlled. Since the outbreak of the epidemic, 15,843 cases of infection have been confirmed in the country, and 821 people have died.
At the end of July, after controlling the initial epidemic situation, Taiwan moved to the second lowest level of restrictions. Despite the gradual easing of restrictions inside the country, the government has not decided to lift restrictions imposed on those coming from abroad. So far, only citizens, residents and people with special humanitarian visas are allowed to enter Taiwan. Each participant must be quarantined for 15 days. As authorities have indicated, these restrictions will likely not be lifted until at least 60 percent have been vaccinated. the country’s population.
“Analyst. Lovely avid bacon reader. Entrepreneur. Dedicated writer. Award winning wine ninja. Subtly endearing reader.”